• Skip to main content
  • Skip to footer

PeDRA

Pediatric Dermatology Research Alliance

  • DONATE
  • Pay 2023 Membership Dues
  • Join PeDRA
  • Login
MENUMENU
  • Contact Us
  • For Patients & Families
        • Patient Support
        • Patient Education
        • Community Spotlight
        • Play Eczema Counts Now!
        • Patient Advisory Committee
        • Find a Pediatric Dermatologist (from SPD)
        • Parents, advocates, and patients over the age of 18 with a direct connection or significant interest in childhood skin disease or pediatric dermatology research are encouraged to join the PeDRA network for free as Community Members.

          Apply Now!

  • Education and Events
        • Virtual Education
        • PeDRA Podcasts
        • Points of Discussion Podcast
        • Mentorship Program
        • SPD/PeDRA Journal Club
        • 2022 PeDRA Annual Conference
        • Dash for Discovery Fun Run/Walk
        • Early Investigator Support
        • Play Eczema Counts Now!
        • Events Calendar
        • Save the Date! The 2023 PeDRA Annual Conference will be held November 9-11, 2023 at the Westin Buckhead Atlanta in Atlanta, GA.

  • Research
        • Grants and Fellowships
        • Resources for Researchers
        • Survey Application
        • Study Application
        • Research Areas
        • Publications
        • Now accepting applications for the Emerging Investigator Research Grants Program and Research Fellowships Program.

  • About
        • Mission & Vision
        • Leadership & Staff
        • Annual Reports & Financials
        • News Archive
        • Our Supporters
        • Our Membership
        • Our Committees
        • Getting to Know You
        • 2022 marked PeDRA’s 10th year of pursuing the vision of changing lives and healing children with skin disease through collaboration and discovery. Visit our 10th Anniversary Page to learn more about the origin of PeDRA and the many accomplishments during the first ten years!

  • Member Login

Webinars

Webinar: New Developments in Patients with Epidermolysis Bullosa

November 8, 2021 By Jenn Dawson

Sponsored Webinar: New Developments in Patients with Epidermolysis Bullosa. In partnership with Amryt Pharma, Lara Wine Lee, MD, PhD and John Browning, MD, FAAD, FAAP, MBA presented a live webinar with a question and answer session on recent advancements in epidermolysis bullosa research.


New Developments in Patients with Epidermolysis Bullosa
Sponsored by Amryt Pharma
Wednesday, December 8, 2021, 5:30 PM PST / 8:30 PM EST

Speakers: Lara Wine Lee, MD, PhD and John Browning, MD, FAAD, FAAP, MBA

watch now

Speakers

Lara Wine Lee, MD, PhD

Dr. Lara Wine Lee is originally from the Washington, DC area. She received her undergraduate degree from Harvard University. She completed the Medical Scientist Training Program at the University of Pennsylvania. She completed general pediatrics residency at the Children’s Hospital of Philadelphia prior to her dermatology residency at the University of Pennsylvania. She subsequently completed fellowship training in pediatric dermatology at the Children’s Hospital of Philadelphia. She joined the dermatology and pediatrics departments at MUSC in 2014. At MUSC she is the director of clinical research for the Department of Dermatology where she guides a robust clinical trials program and a research fellowship as well as mentoring students in the Masters of Science in Clinical Research program. She also serves at the Associate Residency Program Director and the Director of the Pediatric Dermatology Fellowship Program.  Her clinical interests include general pediatric dermatology with specialty interests in pediatric inflammatory skin conditions, vascular anomalies, and genetic skin disorders. 

    John Browning, MD, FAAD, FAAP, MBA

    Dr. Browning obtained his undergraduate degree from Vanderbilt University and his medical degree from the University of Texas Medical Branch in Galveston where he was a member of AOA. He completed a pediatric residency at Baylor College of Medicine in Houston and then another residency in dermatology, also at Baylor College of Medicine where he was Chief Resident. He completed a fellowship in pediatric dermatology at Baylor and Texas Children’s Hospital in 2008.

    Dr. Browning is a clinical assistant professor of pediatrics and dermatology at Baylor College of Medicine and adjunct faculty at UT Health San Antonio as well as UIW School of Medicine. He also serves as the Chief of Dermatology at the Children’s Hospital of San Antonio.

    Dr. Browning is the founder of Texas Dermatology and Laser Specialists where he sees patients, teaches, and is heavily involved in clinical research trials.


      This webinar is being hosted by PeDRA and sponsored by Amryt Pharma.


      PeDRA will evaluate content for suitability for its audience but is not responsible for the creation of content, selection of speakers, or delivery of presentations. Please email us at info@pedraresearch.org with any questions or concerns.

      Filed Under: Education, Education for Researchers, Webinars

      Series: Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata in Children

      April 17, 2021 By Jenn Dawson

      Moderate-to-severe alopecia areata (AA) is associated with negative impacts on quality of life and health outcomes in all age groups. However, the impact on children living with this disease and their families is uniquely severe. Children and their families face the daily burden of a chronic disease, exacerbated by bullying and impact on parental mental health that is particularly severe for a disease with such noticeable manifestations. Recent advances in our understanding of the pathobiology underlying AA have contributed to a promising pipeline of therapeutic options for patients in the near future. Yet, apprehension remains over the consequences of systemic treatment of AA, which is all the more significant in the pediatric population. To address the need for better awareness and understanding of AA, and provide a greater depth of knowledge in the mechanisms underlying emerging treatment options for AA, PeDRA is conducting a six-part educational series Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata in Children.      

      Being hosted by distinguished faculty in pediatric dermatology this non-CME program will include a total of six parts, including three webinars, three podcasts. 


      Part 1: ALOPECIA AREATA – A Clinical Overview
      PRESENTED LIVE: Wednesday, May 19, 2021, 5:00 – 6:00PM PT / 8:00 – 9:00PM ET

      Chairs and Speakers: Leslie Castelo-Soccio MD, PhD and Britt Craiglow, MD

      WATCH NOW
      Audio Only

      Part 2: ALOPECIA AREATA – The Science
      PRESENTED LIVE: Wednesday, June 2, 2021, 5:00 – 6:00PM PT / 8:00 – 9:00PM ET

      Chairs: Leslie Castelo-Soccio, MD, PhD and Britt Craiglow, MD
      Speakers: John O’Shea, MD, and Ali Jabbari, MD, PhD

      watch now
      Audio Only

      Part 3: ALOPECIA AREATA – The Future
      PRESENTED LIVE: Wednesday, June 16, 2021, 5:00 – 6:00PM PT / 8:00 – 9:00PM ET

      Chairs: Chairs: Leslie Castelo-Soccio, MD, PhD and
      Britt Craiglow, MD
      Speaker: Rodney Sinclair, MD, MBBS, FACD

      watch now
      Audio only

      Podcast Part 1: ALOPECIA AREATA – A Conversation with Dr. Carolyn Goh

      Chairs: Leslie Castelo-Soccio, MD, PhD and Britt Craiglow, MD
      Special Guest: Carolyn Goh, MD

      Listen now

      Podcast Part 2: ALOPECIA AREATA – Ask Me Anything

      Chairs: Britt Craiglow, MD and
      Leslie Castelo-Soccio, MD, PhD

      Listen now

      Podcast Part 3: ALOPECIA AREATA – Patient Perspectives

      Chairs: Britt Craiglow, MD and
      Leslie Castelo-Soccio, MD, PhD
      Special Guests: Crystal and Gracie

      Listen now

      FACULTY

      Leslie Castelo-Soccio, MD, PhD

      Co-Chair

      Dr. Castelo-Soccio is Assistant Professor of Dermatology and Pediatrics at the University of Pennsylvania Perelman School of Medicine and Director of Research in the Section of Dermatology at Children’s Hospital of Philadelphia. She maintains board-certification in dermatology and pediatric dermatology. Dr. Castelo-Soccio is dedicated to patient care and research with a goal of improving quality of life for pediatric patients with skin disease. She has a clinical and academic focus on alopecia, hair conditions and genodermatoses with specialty clinics for both hair and genodermatoses. She has worked on creating tools that can be used in both the clinical and research arenas and has a research interest in the microbiome of alopecia areata. As research director for her section, she additionally supports medical students, residents, fellows and colleagues in many other areas of collaborative research. She has been supported by the Dermatology Foundation and the National Alopecia Areata Foundation. She is an active on the medical advisory board for the National Alopecia Areata Foundation and as a leader of the Hair working group for the Pediatric Dermatology Research Alliance.

        Britt Craiglow, MD

        Co-Chair

        Dr. Craiglow is Adjunct Associate Professor of Dermatology at Yale and sees patients in private practice in Fairfield, CT.  Her clinical areas of expertise include inflammatory dermatoses, alopecia, and inherited disorders of keratinization. She has particular interest in medical therapeutics and health-related quality of life. Dr. Craiglow has been a pioneer in the use of Janus kinase inhibitors for alopecia areata and strong advocate for advancement of therapies for those affected by this often devastating disease.    


          SPECIAL GUESTS

          Ali Jabbari, MD, PhD

          Dr. Jabbari is an Associate Professor of Dermatology at the University of Iowa, where he supervises the resident-staffed Hair Disorders Clinic, serves as a Principal Investigator for the University of Iowa Alopecia Areata Registry, and runs a basic science research laboratory.  The major focus of his work is inflammatory and immunoregulatory pathways in alopecia areata. Dr. Jabbari has received funding from the Dermatology Foundation, the National Institutes of Health, and the Department of Veterans Affairs.

            John O’Shea, MD

            John J. O’Shea graduated Phi Beta Kappa from St. Lawrence University and the University of Cincinnati College of Medicine. He carried out a residency in Internal Medicine at the SUNY-Upstate Medical University and subspecialty training and postdoctoral research at the NIH.  He is currently the Director of the Intramural Research Program at the National Institute of Arthritis and Musculoskeletal and Skin Diseases.  

            Dr. O’Shea has made fundamental discoveries related to the basic mechanisms underlying cytokine signal transduction. He and his colleagues first cloned the human tyrosine kinase JAK3 and discovered its role in signaling by interleukin-2.  These insights led to the discovery of JAK3 mutations as a cause of severe combined immunodeficiency.  This led Dr. O’Shea and his colleagues to propose that targeting JAKs would represent a new class of immunomodulatory drugs and now nine JAK inhibitors been approved for the treatment of multiple forms of arthritis, atopic dermatitis and inflammatory bowel disease.  Dr. O’Shea has made many important insights into the role of STAT family transcription factors and more recently, he has made seminal discoveries related to how STATs impact the epigenome.

            Dr. O’Shea has received numerous awards, including the: NIH Director’s Award four times, USPHS Physician Researcher of the Year Award, Irish Immunology Public Lecture Award, Arthritis Foundation’s Howley Prize, Drake Prize, Ross Prize in Molecular Medicine, the Millstein Prize, the AAI-Steinman Award for Human Immunology and the ASCI Harrington Prize. Dr. O’Shea is a member of the American Society of Clinical Investigation, American Association of Physicians and the National Academy of Medicine and was named a Master of the American College of Rheumatology. He has published more than 330 peer-reviewed articles and is on the editorial boards of Immunity and the Journal of Experimental Medicine. ing soon

              Rodney Sinclair, MD, MBBS, FACD

              Rodney Sinclair is a Professorial Associate in the Department of Medicine at the University of Melbourne, Director of Sinclair Dermatology Institute for Research, Education and Clinical Trials (DIRECT) and Professor/Director of Dermatology at the Epworth Hospital, a 700+ bed, not for profit private hospital in Melbourne. He is co-founder and Past-President of the Australasian Society for Dermatology Research (ASDR), co-founder and Past-President of the Australasian Hair and Wool Research Society (AHWRS) and Past–President of the Skin and Cancer Foundation of Victoria. He is a Board Member of the International Society of Dermatology, the International Academy of Cosmetic Dermatology, the ASDR and AHWRS. He was Professor/Director of Dermatology at St Vincent’s Hospital Melbourne from 2005-2013 and in 2012 was awarded Honorary Life Membership of the American Dermatology Association. Prof Sinclair is Secretary General for the International Congress of Dermatology in Melbourne that will be held in November 2021 and Congress President of the World Congress of Hair Research that will be held in Melbourne in April 2022.  In 2021 he will deliver a plenary lecture at the 101st British Association of Dermatology Annual Scientific Meeting. He has supervised over 15 post-graduate research students and co-established the PhD/FACD program in Australia develop clinician scientists.  Professor Sinclair’s contributions to the medical literature can be viewed at here.

                Carolyn Goh, MD

                Dr. Goh is Associate Clinical Professor of Dermatology at David Geffen School of Medicine at UCLA She practices general medical dermatology with a specialty in hair loss and scalp disorders. She did undergraduate studies at Stanford University with a major in Comparative Studies in Race and Ethnicity with a minor in Human Biology. She completed medical school at Weill Medical College of Cornell University with honors in both research and community service. She did an internship in internal medicine at Harbor-UCLA Medical Center and completed her residency at New York-Presbyterian Hospital/Cornell in New York City. Her research and clinical interests are in all types of hair loss including alopecia areata and scarring alopecia. She has been active with patient advocacy groups and local support groups for patients with hair loss. Additionally, she sees children and adults for all skin disorders including eczema, psoriasis, acne, and skin cancer.


                  Special thanks to Pfizer Inc. for their support of this independent medical education program. PeDRA is solely responsible for all program content and the selection of all presenters, authors, moderators, and faculty.

                  Filed Under: Education, Podcasts, Series, Town Halls, Webinars

                  Webinar: Using Social Media to Advance Your Career

                  January 20, 2021 By Jenn Dawson

                  Hosted on February 10, 2021. Learn how to promote your science via social media channels. Featured presenters Dr. John Harris, and Dr. Daniel Sugai shared their experiences with social media and answered questions.

                  This program is run in partnership with the Society for Pediatric Dermatology Junior Faculty/Fellows Committee.


                  Using Social Media to Advance Your Career with Live Q&A
                  Wednesday, February 10, 2021 at 5:30PM PST / 8:30PM EST

                  This event is for PeDRA and SPD members only – pre-registration is required.

                  Hosts: Jiade Yu, MD and Lisa Arkin, MD

                  Speakers
                  John Harris, MD, PhD
                  Daniel Sugai, MD

                  Watch now

                  Speakers

                  Daniel Sugai, MD

                  Dr. Daniel Sugai was born and raised on the Hawaiian island of Oahu where he studied biology and art in college at the University of Hawaii. He then went on and got his M.D. from the University of Hawaii and was Class President and President of his school’s AOA Honor Society. He completed his dermatology training in the Harvard Combined Dermatology Residency Program where he trained at Mass General Hospital/BWH/Beth Israel Deaconess Medical Center/Boston Children’s Hospital. Upon graduating from residency and passing his board certification examination, he moved to Seattle, WA and practices medical, cosmetic and surgical dermatology- seeing pediatrics and adults. He received multiple “Top Doctor” accolades including Seattle Met Magazine Top Doctor 2020. At the start of the pandemic in March/April 2020, Dr. Sugai started a YouTube channel, Instagram and TikTok to help disseminate credible science-backed skin education to the masses. It has become a “second job” and a passion of his and he enjoys connecting with people from all around the globe. 

                    John Harris, MD, PhD

                    Dr. Harris is the Chair of Dermatology, Founding Director of the Vitiligo Clinic and Research Center, and Founding Director of the Autoimmune Therapeutics Institute at UMass Medical School in Worcester, Massachusetts. He is a dermatologist and physician-scientist, caring for patients in a vitiligo specialty clinic and running a large research laboratory focused on understanding disease pathogenesis and developing new treatments. His group integrates basic, translational, and clinical research strategies to accomplish this. As a result, early clinical trials in vitiligo have shown success, and more are being developed. Finally, Dr. Harris founded Villaris Therapeutics, whose entire focus is to develop an effective, long-lasting treatment for vitiligo.

                      Filed Under: Archive, Education, Webinars

                      Webinar: Understanding EB Biology and Recent Advances in EB Clinical Research and Q&A Session

                      December 10, 2020 By Jenn Dawson

                      Hosted on January 11, 2021. PeDRA President-Elect Anna Bruckner, MD, MSCS gave a presentation on basic biology underlying EB and recent advances in EB clinical research. Webinar sponsored by Amryt Research Ltd.


                      Understanding EB Biology and Recent Advances in EB Clinical Research and Q&A Session, Sponsored by Amryt Research Ltd.
                      Monday, January 11, 2021, 5:30 PM PST / 8:30 PM EST

                      Speaker: Anna Bruckner, MD, MSCS

                      WATCH NOW

                      Speaker

                      Anna Bruckner, MD, MSCS

                      Dr. Bruckner is Associate Professor of Dermatology and Pediatrics and at the University of Colorado School of Medicine and Director of Pediatric Dermatology at Children’s Hospital Colorado. She attended Northwestern University as part of the Honors Program in Medical Education, earning her MD in 1997. She completed residencies pediatrics and dermatology at the University of Colorado followed by a fellowship in pediatric dermatology at the University of California San Francisco. She maintains board-certification in dermatology and pediatric dermatology.

                      Dr. Bruckner is passionate about improving outcomes and quality of life for children with skin disorders through patient care, research, education and advocacy. Her academic interests include genetic skin disorders – particularly epidermolysis bullosa (EB), vascular anomalies, atopic dermatitis, and complex patients. She is the principal investigator for the Epidermolysis Bullosa Clinical Research Consortium, a network of North American EB care centers collaborating in clinic research aimed at improving the care and outcomes for patients with EB.

                      Dr. Bruckner is a founding member of the Pediatric Dermatology Research Alliance (PeDRA) and served on PeDRA’s Executive Committee until 2016. She is now the 2022 President-Elect.


                        PeDRA will evaluate content for suitability for its audience but is not responsible for the creation of content, selection of speakers, or delivery of presentations. Please email us at info@pedraresearch.org with any questions or concerns. This webinar is being hosted by PeDRA and sponsored by Amryt Research Ltd.
                        Date of preparation: December 2020. VV-MED-00552

                        Filed Under: Archive, Education, Webinars

                        Webinar: EB-101 Clinical Development Update and Q&A Session

                        October 28, 2020 By Mike Siegel

                        Hosted on November 12, 2020 in partnership with Abeona Therapeutics, this webinar presented cutting edge clinical development updates towards the treatment of epidermolysis bullosa. The webinar featured presentations from Jean Tang, MD, PhD (Professor of Dermatology, Stanford University Medical Center and Principal Investigator, EB-101 pivotal Phase 3 VIITAL study) and Michael Amoroso (Chief Commercial Officer, Abeona) and moderated discussion.


                        EB-101 Clinical Development Update and Q&A Session, sponsored by Abeona Therapeutics
                        Thursday, November 12, 2020 8:00 AM PST / 11:00 AM EST

                        Speakers: Jean Tang, MD, PhD and Michael Amoroso

                        watch now

                        Speakers

                        Jean Tang, MD, PhD

                        Professor of Dermatology, Stanford University Medical Center AND Principal Investigator, EB-101 pivotal Phase 3 VIITAL study

                        Dr. Tang’s research focuses on genetic skin diseases such as Basal Cell Nevus Syndrome and Epidermolysis Bullosa. She studies new ways to treat and prevent NSMC and melanoma. Dr. Tang has led or co-led the conduct and completion of 6 investigator initiated clinical trials in BCC and EB. She received her MD/PhD from Stanford (Biophysics), completed her dermatology residency at Stanford, and then went to UCSF for a 3 year post-doc in mouse genetics, while simultaneously pursuing formal coursework in biostatistics, epidemiology, and clinical trial design in the KL2 CTSI program.

                          Michael Amoroso, MBA

                          Chief Commercial Officer, Abeona

                          Michael Amoroso joined Abeona as Senior Vice President and Chief Commercial Officer in July 2020, bringing over 20 years of product commercialization experience in the biotechnology and pharmaceutical industries with a focus on cell and gene therapies, and a proven track record of launching innovative drugs for rare diseases.

                          Prior to joining Abeona, Mr. Amoroso held various senior level commercial positions at leading biopharmaceutical companies, including Kite, Eisai Inc., Celgene Corporation (now a subsidiary of Bristol-Myers Squibb Company), and Sanofi. At Kite, he was responsible for the company’s worldwide commercial organization leading the commercialization efforts for the autologous CAR T-cell therapy, YESCARTA®, and the future cell therapy pipeline. Before Kite, Mr. Amoroso was Senior Vice President, Americas for Eisai’s Commercial Oncology Business Group, where he was accountable for teams charged with creating and driving commercial strategy and implementation for the company’s approved products and earlier-stage assets. Previously, Mr. Amoroso worked at Celgene for six years in several commercial roles before serving as the organization’s Commercial Lead for CAR T-cell therapy programs. In this capacity, he helped Celgene develop an organizational model to commercialize cell therapies including specialized manufacturing and customer services for patients with lymphoma and myeloma. Before joining Celgene, Mr. Amoroso held various marketing and sales leadership positions over his 10-plus year tenure at Sanofi.

                          Mr. Amoroso earned his M.B.A. in Management from the Stern School of Business, New York University, and his B.A. in Biological Sciences, summa cum laude, from Rider University.


                            This webinar is being hosted by PeDRA and sponsored by Abeona Therapeutics. PeDRA will evaluate content for suitability for its audience but is not responsible for the creation of content, selection of speakers, or delivery of presentations. Please email us at info@pedraresearch.org with any questions or concerns.

                            Filed Under: Archive, Education, Webinars

                            Series: Emerging Therapies for Moderate-to-Severe Atopic Dermatitis in Children

                            September 25, 2020 By Mike Siegel

                            Moderate-to-severe atopic dermatitis is associated with negative impacts on quality of life and health outcomes in all age groups, with the impact on children and families being uniquely severe. However, the rapid pace of drug development and uncertainty around novel medications may impact the shared decision-making process and lead to suboptimal treatment of many children. Thus, educating pediatric dermatologists and allergists is critical to positively affect treatment decisions and improve long-term outcomes. In addition, engaging experts in pediatric dermatology and allergy to consider what are the most important research issues in atopic dermatitis is important to direct future efforts. To address this need and help fill the gap left by canceled conferences in 2020, PeDRA is conducting a six-part educational series Emerging Therapies for Moderate-to-Severe Atopic Dermatitis in Children.      

                            Being hosted by distinguished faculty in pediatric dermatology and allergy/immunology, this non-CME program will include a total of six parts, including two webinars, two podcasts, and two virtual meetings/townhalls. 


                            Part 1: PEDIATRIC ATOPIC DERMATITIS – New and Emerging Systemic Therapies: An Overview
                            RECORDED LIVE: Tuesday, October 6, 2020, 5:15 – 6:15PM PDT / 8:15 – 9:15PM EDT

                            Chair: Lawrence Eichenfield, MD
                            Speakers: Megha Tollefson, MD and Bob Geng, MD
                            Panel: Wynnis Tom, MD and Dawn Davis, MD

                            View Full Agenda

                            5:15 – 5:20 – Introduction
                            5:20 – 5:37 – Biologics – Overview and translation to practice
                            5:37 – 5:49 – JAK-inhibitors
                            5:49 – 6:01 – Mechanisms of action and allergy perspectives
                            6:01 – 6:15 – Moderated discussion with audience

                            Watch NOW

                            Part 2: PEDIATRIC ATOPIC DERMATITIS – Algorithms of the Future
                            RECORDED LIVE: Tuesday, October 13, 2020, 5:15 – 6:15PM PDT / 8:15 – 9:15PM EDT

                            Chair: Lawrence Eichenfield, MD
                            Speakers: Dawn Davis, MD and Wynnis Tom, MD
                            Panel: Megha Tollefson, MD and Bob Geng, MD

                            View Full Agenda

                            5:15 – 5:20 – Introduction
                            5:20 – 5:32 – New topicals for moderate to severe disease
                            5:32 – 5:42 – New and traditional systemics: where do they fit?
                            5:42 – 6:00 – Considerations when selecting appropriate therapy for the appropriate patient
                            6:00 – 6:15 – Interactive discussion on “hot” research issues in moderate to severe atopic dermatitis for pediatric dermatologists and allergists

                            Watch now

                            Part 3: Systemic Therapy for Moderate-to-Severe AD in Children: Where are We?
                            AVAILABLE NOW

                            Host: Lawrence Eichenfield, MD
                            Guests: Dawn Davis, MD, Bob Geng, MD, and Wynnis Tom, MD
                            Guests

                            LISTEN NOW:

                            https://podcasts.captivate.fm/media/42f1f451-4c7a-4c47-adc7-3f8302d68e01/ad-1st-podcast-online-audio-converter.mp3

                            Subscribe to PeDRA Podcasts


                            Part 4: Systemic Therapy for Moderate-to-Severe AD in Children: Where are We?
                            Tuesday, December 8, 2020 5:15 – 6:15PM PST / 8:15 – 9:15PM EST

                            Host: Lawrence Eichenfield, MD
                            Guests: Dawn Davis, MD, Bob Geng, MD, and Wynnis Tom, MD
                            Special Guests: Emma Guttman-Yassky, MD, PhD and Eric Simpson, MD

                            LISTEN NOW:

                            https://podcasts.captivate.fm/media/5f6ed858-27df-4ec9-906d-ba7e362373c6/ad-where-are-we-town-hall-use-this-one.mp3

                            Subscribe to PeDRA Podcasts


                            Part 5: Patient Perspectives on Therapies for Moderate-to-Severe AD in Children
                            AVAILABLE NOW

                            Host: Dawn Davis, MD
                            Special Guests: Charlene Miciano and Sarah Pry

                            LISTEN NOW:

                            https://podcasts.captivate.fm/media/1cdbecd8-cf74-4b2b-ae80-4a4db52f1e88/patient-perspectives-podcast.mp3

                            Subscribe to PeDRA Podcasts


                            Part 6: Patient Perspectives on Therapies for Moderate-to-Severe AD in Children
                            Tuesday, January 5, 2021, 5:15 – 6:15PM PST / 8:15 – 9:15PM EST

                            An open discussion with faculty and patient advocates in follow-up to the second podcast. Bring your questions or just listen in.

                            Host: Dawn Davis, MD
                            Guests: Lawrence Eichenfield, MD, Bob Geng, MD, and Wynnis Tom, MD
                            Special Guests: Korey Capozza, MPH from Global Parents for Eczema Research and Wendy Smith Begolka, MBS from the National Eczema Association

                            LISTEN NOW:

                            https://podcasts.captivate.fm/media/1ddde529-02a1-49c7-9539-5f531f69664f/patient-perspectives-ad-th2final.mp3

                            Subscribe to PeDRA Podcast


                            FACULTY

                            Lawrence Eichenfield, MD

                            Chair

                            Professor of Dermatology and Pediatrics
                            Chief, Pediatric and Adolescent Dermatology
                            Vice Chair, Department of Dermatology
                            University of California, San Diego and Rady Children’s Hospital, San Diego

                              Bob Geng, MD

                              Assistant Professor of Medicine and Pediatrics
                              Divisions of Adult and Pediatric Allergy & Immunology
                              Co-Director of the Allergy Asthma Foundation of America sponsored UCSD Pediatric Severe Asthma Program
                              Allergy/Immunology Director of the Multidisciplinary Atopic Dermatitis Program
                              University of California, San Diego and Rady Children’s Hospital, San Diego

                                Dawn Davis, MD

                                Professor of Dermatology and Pediatrics
                                Division Chair, Clinical Dermatology
                                Director, Section of Pediatric Dermatology
                                Mayo Clinic Rochester

                                  Megha Tollefson, MD

                                  Associate Professor of Dermatology and Pediatrics
                                  Consultant, Dermatology
                                  Consultant, Pediatric and Adolescent Medicine
                                  Mayo Clinic Rochester

                                    Wynnis Tom, MD

                                    Clinical Professor of Dermatology and Pediatrics
                                    Fellowship Program Director
                                    Pediatric & Adolescent Dermatology
                                    University of California, San Diego and Rady Children’s Hospital, San Diego


                                      SPECIAL GUESTS

                                      Emma Guttman-Yassky, MD, PhD

                                      Vice Chair for Research
                                      Incoming System Chair of the Kimberly and Eric J. Waldman Department of Dermatology
                                      Icahn School of Medicine at Mount Sinai

                                        Charlene Miciano

                                        Charlene is a college student from San Diego majoring in bioinformatics. Her experience with eczema growing up influenced her to become an ambassador for the National Eczema Association. When she’s not coding, she enjoys music in many forms, whether it be playing piano or ukulele, doing karaoke, or going to concerts.

                                          Korey Capozza, MPH

                                          Korey is the founder and executive director of Global Parents for Eczema Research and the mother of a child with moderate to severe eczema. Her professional background is in public health, collaborative leadership, and patient-centered research.

                                            Eric Simpson, MD

                                            Professor of Dermatology
                                            Oregon Health and Science University

                                              Sarah Pry

                                              Sarah is a mother of 2, Aiden age 12 and Bayle age 8. Aiden has severe eczema. Sarah works full time as an insurance agent in TN and in what spare time she has as a mom, she plays with her kids. She also loves to advocate and learn from the experts by volunteering or helping anyway that she can.

                                                Wendy Smith Begolka, MBS

                                                Ms. Smith Begolka is the VP for Scientific and Clinical Affairs for the National Eczema Association (NEA) where she guides the evolution and growth of NEA’s patient-centric research and clinical care efforts across the organization and with diverse stakeholders. Prior to joining NEA in 2018, she conducted biomedical laboratory research investigating immunological pathways of autoimmune disease at Northwestern University, and for over a decade, led the development of American Academy of Dermatology clinical guidelines and the application of science to the intersecting areas of quality, education, and advocacy. Her 25+ year scientific career has focused on advancing research, the use of scientific discovery and findings to support improved therapeutic options and clinical care, and the translation of research data for educational, quality, advocacy, and policy initiatives.


                                                  Special thanks to Pfizer Inc. for their support of this independent medical education program.  PeDRA is solely responsible for all program content and the selection of all presenters, authors, moderators, and faculty.

                                                  Filed Under: Archive, Education, Podcasts, Series, Town Halls, Webinars

                                                  Webinar: From the NICU to Eczema and the Value of Research Funding

                                                  July 13, 2020 By Jenn Dawson

                                                  Tune in to hear Jennifer Schoch, MD from University of Florida discuss her research in the microbiome and eczema, and learn about the value of PeDRA funding.

                                                  Jennifer Schoch, MD

                                                  Jennifer Schoch, MD is Pediatric Dermatologist and Assistant Professor of Dermatology at the University of Florida. She is the recipient of a PeDRA Pilot Grant (2018), SPD/PeDRA Weston Career Development award (2019-20), PeDRA Shark Tank Award (2020-21) and an NIH KL2 Award (2020-22).

                                                    Filed Under: Archive, Education, Webinars

                                                    Webinar: Hamartomas and midline anomalies in association with infantile hemangiomas, PHACE, and LUMBAR syndromes

                                                    June 23, 2020 By Jenn Dawson

                                                    Olivia Davies, MD discusses the findings of a recent publication – Hamartomas and midline anomalies in association with infantile hemangiomas, PHACE, and LUMBAR syndromes.

                                                    Olivia Davies, MD

                                                    Dr. Davies was the 2019-2021 PeDRA fellow and is now a dermatology resident at Harvard University.

                                                      Filed Under: Archive, Education, For Patients, Webinars

                                                      • Go to page 1
                                                      • Go to page 2
                                                      • Go to Next Page »

                                                      Footer

                                                      • Our Membership
                                                      • For Patients
                                                      • For Researchers
                                                      • Governance Policies
                                                      • Financial Conflict of Interest Policy
                                                      • Jobs at PeDRA
                                                      • Facebook
                                                      • Instagram
                                                      • LinkedIn
                                                      • Twitter
                                                      • YouTube
                                                      Sign up to receive emails from PeDRA
                                                      Join PeDRA
                                                      Donate

                                                      Copyright © 2023 · Pediatric Dermatology Research Alliance (PeDRA) · All Rights Reserved. · Privacy Policy